Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical utility of chromogranin A in SDHx-related paragangliomas.

European journal of clinical investigation - 1 Apr 2014

Zuber Samuel, Wesley Robert, Prodanov Tamara, Eisenhofer Graeme, Pacak Karel, Kantorovich Vitaly

Abstract excerpt

BACKGROUND: Measurement of plasma/urinary catecholamine metabolites--especially normetanephrine (NMN)--represents a gold standard in biochemical detection of succinate dehydrogenase subunit B (SDHB) and D (SDHD)-related pheochromocytomas (PHEO) and paragangliomas (PGL). This study was designed to assess diagnostic utility of chromogranin A (CgA) alone or in combination with NMN in patients with PHEO/PGL related...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromogranin A
Share to Biomarkers
Share to Child, Preschool

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Head and Neck Neoplasms

Share to Paraganglioma

Share to ROC Curve

Share to Sensitivity and Specificity

Share to Succinate Dehydrogenase

Source

Identifiers

PMID: 24467715
DOI: 10.1111/eci.12245

Genes

SDHB
SDHD

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical utility of chromogranin A in SDHx-related paragangliomas.PMID 24467715Read ↗

Clinical aspects of SDHx-related pheochromocytoma and paraganglioma.Semantic proximity Read ↗

The Changing Paradigm of Head and Neck Paragangliomas: What Every Otolaryngologist Needs to Know.Semantic proximity Read ↗

Succinate: A Serum Biomarker of SDHB-Mutated Paragangliomas and Pheochromocytomas.Semantic proximity Read ↗

Clinical presentations, biochemical phenotypes, and genotype-phenotype correlations in patients with succinate dehydrogenase subunit B-associated pheochromocytomas and paragangliomas.Semantic proximity Read ↗

Pheochromocytomas and extra-adrenal paragangliomas detected by screening in patients with SDHD-associated head-and-neck paragangliomas.Semantic proximity Read ↗

Treatment responses to antiangiogenetic therapy and chemotherapy in nonsecreting paraganglioma (PGL4) of urinary bladder with SDHB mutation: A case report.Semantic proximity Read ↗

New Insights into the Nuclear Imaging Phenotypes of Cluster 1 Pheochromocytoma and Paraganglioma.Semantic proximity Read ↗

Necessity for long-term follow-up of patients with head and neck paraganglioma and mutation in the succinate dehydrogenase genes: an index case report and literature review.Semantic proximity Read ↗

Clinical Practice Guidance: Surveillance for phaeochromocytoma and paraganglioma in paediatric succinate dehydrogenase gene mutation carriersSemantic proximity Read ↗

Molecular imaging in hereditary succinate dehydrogenase mutation-related paragangliomas.Semantic proximity Read ↗

Mediastinal paragangliomas: association with mutations in the succinate dehydrogenase genes and aggressive behavior.Semantic proximity Read ↗

Colorectal paragangliomas with immunohistochemical deficiency of succinate dehydrogenase subunit B.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.